Published 7 days ago • loading... • Updated 7 days ago
Helus Pharma Reports First Quarter Fiscal 2027 Financial Results and Recent Business Highlights
Summary by mykxlg.com
3 Articles
3 Articles
+2 Reposted by 2 other sources
Helus Pharma Reports First Quarter Fiscal 2027 Financial Results and Recent Business Highlights
Appointed Michael Halstead, former President of Intra-Cellular Therapies, as Chief Executive Officer to lead Helus Pharma through late-stage development and commercialization
Coverage Details
Total News Sources3
Leaning Left1Leaning Right1Center1Last Updated34% Left, 33% Center, 33% Right
Bias Distribution
- 34% of the sources lean Left, 33% of the sources are Center, 33% of the sources lean Right
34% Left
L 34%
C 33%
R 33%
Factuality
To view factuality data please Upgrade to Premium







